Biotech Investments

Discover Tomorrow's Blockbusters Today. Independent Medical Rating Agency for Biotech and Pharmaceutical Assets. Based in Switzerland. No Investment Advice.

[Biotech Investments @BiotechInvsts]

Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market.
https://t.co/pkBLls5HLJ

[Biotech Investments @BiotechInvsts]

NASH on the Cusp: An Emerging Market Opportunity. Great article by @biospace on the market opportunity of NASH.
https://t.co/LJE1mPOSIl

[Biotech Investments @BiotechInvsts]

Kinarus Therapeutics signed licensing agreement to extend cash for operations. Group of shareholders received an exclusive license to develop KIN001 to treat IPF.
https://t.co/LrjN3QS3xj

[Biotech Investments @BiotechInvsts]

ViGeneron announces EMA approval of clinical trial application for VG901, a gene therapy to treat Retinitis Pigmentosa.
https://t.co/OygeyXpzi8

[Biotech Investments @BiotechInvsts]

Interested in the future of #alzheimersdisease treatment?
We have rated the whole global #clinical research #pipeline using our sophisticated #asset rating system.

Discover the most interesting drug candidates here:
https://t.co/I9KOr9dCOp

@alzassociation @alzheimerssoc

[Biotech Investments @BiotechInvsts]

Discover Biotech Investments' official M&A target list for the biotech sector for H2 2023. Several rumors and possible acquisitions could materialize in the coming months.
https://t.co/UoCvMUBEWS

[Biotech Investments @BiotechInvsts]

Harmony Biosciences Holdings announces a definitive agreement to acquire Zynerba Pharmaceuticals. Acquisition expands pipeline and adds innovative potential new therapeutic option for rare/orphan neuropsychiatric disorders with high unmet medical needs.
https://t.co/3rRwlkHWaV

[Biotech Investments @BiotechInvsts]

Amphastar Pharmaceuticals exceeds expectations with strong Q2 2023 financial results. Share with a strong YTD performance of +132%.
https://t.co/1yO9AcXEtW

[Biotech Investments @BiotechInvsts]

Newron Pharmaceuticals publishes financial results and operational highlights for the first half year 2023. Great progress on the development of its potential new #Schizophrenia drug Evenamide.
https://t.co/frCqisJ39M

[Biotech Investments @BiotechInvsts]

CureVac announces dosing of first participant in phase 2 study of modified #COVID19 mRNA #vaccine candidates developed in collaboration with GSK.
https://t.co/h9hm0aacyD

[Biotech Investments @BiotechInvsts]

Amphastar Pharmaceuticals completes acquisition of BAQSIMI® from Eli Lilly, providing the company with a branded product with growing sales and strong gross margin.
https://t.co/ItCp3t3i92

[Biotech Investments @BiotechInvsts]

Kinarus Therapeutics, developing novel therapeutics to treat viral, respiratory and ophthalmic diseases, announces the signing of subordinated bridge loan agreements with existing shareholders to ensure further liquidity.
https://t.co/4v5HUTU2Wm

[Biotech Investments @BiotechInvsts]

Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives.
https://t.co/7PBnKc0wzx

[Biotech Investments @BiotechInvsts]

Relief Therapeutics, a #Swiss #biopharma company committed to delivering innovative treatments for #RareDisease, announces CHF 5 million private placement.
https://t.co/TAjJdEQ0tG

[Biotech Investments @BiotechInvsts]

Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023 for its oversubscribed EUR 130M cross-over financing in February 2023.
https://t.co/2pTgX9UPpY

#investment #stockmarketnews #biotech #Pharmaceutical

[Biotech Investments @BiotechInvsts]

Encoded Therapeutics lays off 10% of staff nearly 3 years after $135M series D after a critical assessment of the company’s priorities.
https://t.co/yZaNotwvuZ

[Biotech Investments @BiotechInvsts]

Pharmaceutical manufacturer Dermapharm acquires a significant interest in the Austrian Montavit.
https://t.co/LUIZMmjNBd

#pharmaceuticals #investments #InvestmentNews

[Biotech Investments @BiotechInvsts]

Epigenomics AG in well advanced negotiations with an US based strategic investor on the acquisition of almost all assets of the company.
https://t.co/ee2VeFq3EG

#oncology #stockmarkets #stockmarketnews #investments

[Biotech Investments @BiotechInvsts]

Abivax stock now represented in the MSCI indexes, reflecting the evolution of the world’s equity markets to support investors building effective portfolios based on risk and return assessments.
https://t.co/gbq5z5V1S5

#biotech #Pharmaceutical #stockmarkets #news

[Biotech Investments @BiotechInvsts]

Interested in #biotech stocks? Below you can find our official takeover target list for H2 2023.
https://t.co/UoCvMUBEWS

#investments #InvestmentOpportunities #StockMarket #stockmarketnews #news #NewsUpdate